Aastrom Biosciences, Inc. (ASTM) Reports Second-Quarter and First-Half 2013 Financial Results
8/8/2013 9:46:59 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ANN ARBOR, Mich., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today reported financial results for the quarter and six months ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by